EcoDrugPlus

Renin-Like

Ensembl ID : ENSSTUG00000032390
Gene Symbol: LOC115166437
3 Cross references
213 Possible Orthologues:

Renin-Like

Ensembl ID : ENSSTUG00000013416
Gene Symbol: LOC115168453
3 Cross references
213 Possible Orthologues:

Retinoic Acid Receptor Rxr-Alpha-A

Ensembl ID : ENSSTUG00000024378
Gene Symbol: LOC115204142
3 Cross references
219 Possible Orthologues:

Retinoic Acid Receptor Rxr-Alpha-A-Like

Ensembl ID : ENSSTUG00000023308
Gene Symbol: LOC115159498
3 Cross references
221 Possible Orthologues:

Retinoic Acid Receptor Rxr-Alpha-B-Like

Ensembl ID : ENSSTUG00000036175
Gene Symbol: LOC115164896
2 Cross references
175 Possible Orthologues:

Retinoic Acid Receptor Rxr-Beta-A-Like

Ensembl ID : ENSSTUG00000011327
Gene Symbol: LOC115186134
3 Cross references
203 Possible Orthologues:

Retinoic Acid Receptor Rxr-Beta-A-Like

Ensembl ID : ENSSTUG00000045222
Gene Symbol: LOC115177095
3 Cross references
204 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSSTUG00000041103
Gene Symbol: RARB
3 Cross references
384 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSSTUG00000047543
Gene Symbol: RARB
3 Cross references
390 Possible Orthologues:

Retinoic Acid Receptor Beta-Like

Ensembl ID : ENSSTUG00000035391
Gene Symbol: LOC115178067
2 Cross references
374 Possible Orthologues:

Retinoic Acid Receptor Beta-Like

Ensembl ID : ENSSTUG00000043224
Gene Symbol: LOC115176963
2 Cross references
374 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSSTUG00000003589
Gene Symbol: RARG
3 Cross references
369 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).